The DATURA trial aims to assess whether an intensified initial TB treatment could increase survival in hospitalised, HIV-infected adults and adolescents compared to the standard TB treatment regime. The first DATURA participant was enrolled in Ignace Deen Hospital, Conakry, Guinea on 21 April 2022.
We use cookies on our website to enhance your browsing experience, analyze site traffic, and personalize content. By clicking "Accept All," you consent to the use of all cookies. However, you may visit "Cookie Settings" to provide controlled consent.